These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9544519)

  • 1. An optimal design for screening trials.
    Wang YG; Leung DH
    Biometrics; 1998 Mar; 54(1):243-50. PubMed ID: 9544519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal two-stage design for a series of pilot trials of new agents.
    Yao TJ; Venkatraman ES
    Biometrics; 1998 Sep; 54(3):1183-9. PubMed ID: 9750258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal sample size for a series of pilot trials of new agents.
    Yao TJ; Begg CB; Livingston PO
    Biometrics; 1996 Sep; 52(3):992-1001. PubMed ID: 8805764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sample-size-optimal Bayesian procedure for sequential pharmaceutical trials.
    Cressie N; Biele J
    Biometrics; 1994 Sep; 50(3):700-11. PubMed ID: 7981396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The delta and epsilon errors in the assessment of cancer clinical trials.
    Staquet MJ; Rozencweig M; Von Hoff DD; Muggia FM
    Cancer Treat Rep; 1979; 63(11-12):1917-21. PubMed ID: 526924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal conditional error functions for the control of conditional power.
    Brannath W; Bauer P
    Biometrics; 2004 Sep; 60(3):715-23. PubMed ID: 15339294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal and minimax three-stage designs for phase II oncology clinical trials.
    Chen K; Shan M
    Contemp Clin Trials; 2008 Jan; 29(1):32-41. PubMed ID: 17544337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential equivalence testing and repeated confidence intervals, with applications to normal and binary responses.
    Jennison C; Turnbull BW
    Biometrics; 1993 Mar; 49(1):31-43. PubMed ID: 8513110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design considerations in crossover trials with a single interim analysis and serial patient entry.
    Cook RJ; Willan AR
    Biometrics; 1996 Jun; 52(2):732-9. PubMed ID: 8672709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of multistage testing times and critical values in clinical trials.
    Brittain EH; Bailey KR
    Biometrics; 1993 Sep; 49(3):763-72. PubMed ID: 8241372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal spending functions for asymmetric group sequential designs.
    Anderson KM
    Biom J; 2007 Jun; 49(3):337-45. PubMed ID: 17623339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further results on a multiple-testing procedure for clinical trials.
    Seigel D; Milton RC
    Biometrics; 1983 Dec; 39(4):921-8. PubMed ID: 6671127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient group sequential designs when there are several effect sizes under consideration.
    Jennison C; Turnbull BW
    Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated confidence intervals for adaptive group sequential trials.
    Mehta CR; Bauer P; Posch M; Brannath W
    Stat Med; 2007 Dec; 26(30):5422-33. PubMed ID: 17918195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On determination of sample size in hierarchical binomial models.
    Zou KH; Normand SL
    Stat Med; 2001 Jul; 20(14):2163-82. PubMed ID: 11439428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.